Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C4BPB | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | DNMT3A | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | KCNN1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | SLC30A6 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | TMEFF2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | NFKB1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | RP11-1212A22.4 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | NCKAP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | TSNAX | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | GTF3C5 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |